|
Latest News
Med-El DaCapo Rechargeable Battery Pack Approved!
Date: 11/11/2008
Life Systems is pleased to announce that the DaCapo Battery Pack is approved in Australia. The DaCapo compliments the recent approval of the new Maestro System from Med-El including the SONATATI100, PULSARCI100 implants and the Opus 2 Speech processor. The industry leading complete system is now available to meet the hearing needs of Australians.
Lead Locking Device Introduced
Date: 11/11/2008
Life Systems Medical is happy to announce the introduction of the newest and most user friendly cardiac pacemaker and implantable defib. removal device known as the Lead Locking Device – Easy. The device enables physicians to safely and easily remove chronic cardiac pacing leads without the usual trauma associated with previous methods.
Quick Cross Approved
Date: 11/11/2008
The Approval of Quick Cross in Australia has enabled vascular and interventional radiologists the access to one of Spectranetics most outstanding products. The Quick Cross Support Catheters are guide wire exchange and infusion devices designed for use in the vascular system. The catheters are intended to support a guidewire during the delivery of saline solutions or diagnostic contrast agents.
CryoCath Reports Positive 6-Month Follow Up from U.S. AFIB Trial
Date: 08/03/2007 Montreal, Canada
Of the total 33 patients treated during the feasibility stage, the second cohort of 18 patients, which have been treated with 23mm or 28mm catheters as in the pivotal trial, has now reached the 6-month mark. All patients from the second cohort were free from detectable AFIB at six months. More information.
Frostbyte® CryoSurgical Clamp Approved in Australia
Date: 01/2007 Melbourne
CryoCath Technologies Cryo Surgical Clamp - Frostbyte® - is approved for commercial sale in Australia for the surgical treatment of Atrial Fibrillation. The Frostbyte® offers a unique compliment to the Surgifrost Probe currently available in Australia at 7cm and 10cm lengths. The Frostbyte® comes with a built in Surgifrost probe that allows the user to first transmurally isolate the pulmonary veins before easily removing the built in SurgiFrost Probe to complete the lesion set quickly and effectively.
CryoCath Provides 12 Month Update on Pivotal AF Study
Date: 12/12/2006 Canada
CryoCath Technologies today announced 12 month follow up data from during the feasibility stage of its STOP AF Trial. This pivotal trial is assessing the company's proprietary Arctic Front catheter to treat Atrial Fibrillation. To summarize the results, all original 15 patients AF free at six months, that attended their 12 month visit remain AF free; all 15 patients are off AAD's, and all of the remaining 18 patients have similar freedom from AF levels at 3 and 6 months are all of AAD's. More information.
Ovatio Family of SORIN GROUP's leading ICD's Approved in Australia
Date: 10/2006 Melbourne
SORIN GROUP's industry leading ICD family "Ovatio" are approved for commercial sale in Australia. The Ovatio family of ICD's offer patients and physicians the smallest physiologically shaped device in VR, DR and CRT-D options. With advanced algorithms pioneered in the Symphony family of pacemakers such as AAISafeR in order to reduce harmful ventricular pacing to 0.1% in patients with AV conduction disorders, the Ovatio also features PARAD+, the clinically proven algorithm for industry leading specificity to reduce inappropriate shocks. The Ovatio also features Brady Tachy Overlap (BTO) allowing the pacing in the Slow VT zone. The Ovatio family is available today!
Cryocath's Arctic Front balloon catheter a success
Date: 12/09/2006
At the recent 15th Annual World Congress in Cardiac Electrophysiology and Cardiac Techniqes in Nice, France, Dr Jordaens reported on his 26 patient study of the efficacy of treating paroxysmal AF with the Arctic Front Cryotherapy Catheter. Dr Joraens reported a 100% accute success rate. At three month follow up 87% were AF free, off all anti-arrhythmic drugs and free of stenosis, thrombosis and esophageal perforation.
Ela's focus on advanced physiologically friendly pacemakers is a first.
Date: 01/04/2006
Ela have focussed their attention in the field of Cardiac rhythm into the development of the most advanced physiologically friendly pacemaker available today and have developed the most advanced pacing mode to offer an almost complete reduction in deleterious ventricular pacing-AAISafeR. This is the only mode available to manage all three types of Paroxysmal AV block plus AV conduction disorders at night and during exercise. With unrivalled 0.01% ventricular pacing the Symphony2 is certainly a success.
Symphony Pacing System provides unparalleled reduction in Ventricular Pacing
Date: 20/12/2005
The Ela Medical Symphony with AAIsafeR minimizes ventricular pacing to 0.1% in patients with intrinsic conduction disorders. It is the only pacemaker that deals with all three degrees of AV Block and pauses and has specific treatment for night variations and exercise conditions. The Symphony has comprehensive diagnostic features coupled with AIDA+ programming to provide physicians with a unique picture on the patients intrinsic AV conduction.
Spiderflash is approved for Australian patients
Date: 20/12/2005
The Ela Medical Spiderflash 30 day event monitor is added to the Spiderview Holter monitor and Agilis ABP currently available in Australia. This market leading brand of products provide excellent diagnostic capabilities with today's digital simplicity and ease of use. Robust design with especially engineered lead attachment ensure durability of lead contact to the device.
|
